Spine Tumor clinical trials at UCSF
2 research studies open to eligible people
A spine tumor is an abnormal growth in or around the spinal cord. UCSF is studying how ketamine affects nerve signals during spine surgery. Another study is collecting information on patients with metastatic spine tumors.
Ketamine on Intraoperative Motor Evoked Potentials
open to eligible people ages 18-100
The goal of this clinical trial is to learn about the effect of ketamine on intraoperative motor evoked potentials in adult patients undergoing thoracolumbar spinal fusions. Participants will undergo a standard anesthetic. In addition to the standard anesthetic, the patients will be administered increasing doses of ketamine with motor-evoked potentials being measured at each dose, to assess any impacts.
San Francisco, California
Metastatic Tumor Research and Outcomes Network
open to eligible people ages 18 years and up
The registry aims to collect patient information such as patient demographics, co-morbidities, clinical, diagnostic, and therapeutic data, as well as information on adverse events and HRQOL outcomes specific for patients with metastatic spine tumor(s).
San Francisco, California and other locations
Our lead scientists for Spine Tumor research studies include Marc Buren, MD Dean Chou, MD.
Last updated: